ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
InMode Ltd

InMode Ltd (INMD)

17.47
-0.54
( -3.00% )
업데이트: 00:07:33

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
17.47
매수가
17.46
매도가
17.48
거래량
150,087
17.325 일간 변동폭 18.20
14.87 52주 범위 26.80
market_cap
전일 종가
18.01
개장가
18.145
최근 거래 시간
1
@
17.47
마지막 거래 시간
00:07:29
재정 규모
US$ 2,642,034
VWAP
17.6033
평균 볼륨(3m)
1,169,982
발행 주식
83,982,462
배당수익률
-
주가수익률
7.58
주당순이익(EPS)
2.36
매출
492.05M
순이익
197.92M

InMode Ltd 정보

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed product... InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, Evolve, Evoke, and Morpheus8. The majority of its revenue comes from the United States. 더 보기

섹터
Electromedical Apparatus
산업
Electromedical Apparatus
웹사이트
본부
Yokneam, North, Isr
설립됨
-
InMode Ltd is listed in the Electromedical Apparatus sector of the 나스닥 with ticker INMD. The last closing price for InMode was US$18.01. Over the last year, InMode shares have traded in a share price range of US$ 14.87 to US$ 26.80.

InMode currently has 83,982,462 shares in issue. The market capitalisation of InMode is US$1.51 billion. InMode has a price to earnings ratio (PE ratio) of 7.58.

INMD 최신 뉴스

InMode to Present at Upcoming Investor Conferences

InMode to Present at Upcoming Investor Conferences PR Newswire YOKNEAM, Israel, Nov. 6, 2024 YOKNEAM, Israel, Nov. 6, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of...

InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024)

InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first...

InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories

InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories PR Newswire IRVINE, Calif., Oct. 24, 2024...

InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024

InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024 PR Newswire YOKNEAM, Israel, Oct. 10, 2024 Expects Q3 Revenue Between $130.0 Million -$130.1...

InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy

InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy PR Newswire YOKNEAM, Israel, Oct. 1, 2024 YOKNEAM...

InMode Announces Share Repurchase Program of Up to 7.68 Million Shares

InMode Announces Share Repurchase Program of Up to 7.68 Million Shares PR Newswire YOKNEAM, Israel, Sept. 10, 2024 YOKNEAM, Israel, Sept. 10, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a...

InMode to Present at 2024 Baird Global Healthcare Conference

InMode to Present at 2024 Baird Global Healthcare Conference PR Newswire YOKNEAM, Israel, Sept. 4, 2024 YOKNEAM, Israel, Sept. 4, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-2.37-11.945564516119.8419.8417.325100175418.92378371CS
4-0.21-1.1877828054317.6819.8416.92109529218.34701227CS
121.056.3946406820916.4219.8414.87116998216.92629282CS
26-0.59-3.2668881506118.0619.8414.87117660417.30486786CS
52-4.77-21.447841726622.2426.814.87136253619.58389067CS
156-77.21-81.548373468594.6895.239914.87159850031.21850427CS
260-33.57-65.771943573751.0418013.14135579139.58029457CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
HCWBHCW Biologics Inc
US$ 1.04
(253.02%)
176.32M
APLMApollomics Inc
US$ 0.1496
(56.00%)
358.12M
SINTSiNtx Technologies Inc
US$ 2.90
(42.16%)
30.19M
VINOGaucho Group Holdings Inc
US$ 1.88
(37.23%)
12.17M
FATEFate Therapeutics Inc
US$ 2.6797
(32.66%)
7.34M
CMAXCareMax Inc
US$ 0.80
(-52.38%)
281.59k
NGNENeurogene Inc
US$ 21.05
(-39.01%)
501.98k
AILEiLearningEngines Inc
US$ 0.9159
(-38.94%)
978.38k
SGDSafe and Green Development Corporation
US$ 1.81
(-31.95%)
141.46k
KSCPKnightscope Inc
US$ 14.2227
(-28.78%)
154.87k
APLMApollomics Inc
US$ 0.1506
(57.04%)
358.28M
HCWBHCW Biologics Inc
US$ 1.03
(249.63%)
176.55M
ELABElevai Labs Inc
US$ 0.0227
(2.71%)
81.09M
NVDANVIDIA Corporation
US$ 138.4896
(-2.46%)
58.36M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 21.45
(14.64%)
45.08M